咳止めシロップ市場の2030年までの予測：製品タイプ、年齢層、流通チャネル、地域別の世界分析

Stratistics MRCによると、世界の咳止めシロップ市場は2023年に63億1,209万米ドルを占め、予測期間中のCAGRは4.8%で成長し、2030年には87億6,400万米ドルに達すると予測されています。

咳の症状を治療するために頻繁に使用される市販薬は咳止めシロップです。咳止めシロップには通常、去痰薬、咳止め薬、時には抗ヒスタミン薬が有効成分として含まれています。その主要目的は、喉の炎症を和らげ、咳の衝動を抑え、粘液を緩めるように促すことです。さらに、製剤によっては解熱鎮痛剤を含むこともあります。咳止めシロップは、液体やシロップなどさまざまな形態があり、使い方は簡単です。

米国肺協会によると、適切な呼吸器の健康は全身の健康にとって極めて重要であり、定期的な運動は肺機能の維持に貢献します。

呼吸器疾患の頻度

咳止めシロップの需要は、風邪、インフルエンザ、アレルギーなどの呼吸器疾患の流行によって大きく左右されます。世界中で多くの人々がこれらの病気に苦しんでいるため、咳止め製品が常に必要とされています。さらに、咳止めシロップは、呼吸器系の問題に関連する過敏な症状を迅速かつ効率的に緩和したい人々にとって、頼りになる選択肢となっています。

根本的な原因への対処に限界がある

咳止めシロップは、呼吸器疾患の根本的な原因ではなく、主にその症状を治療するものです。咳やそれに伴う不快感は緩和されるが、病気の根本的な原因は治療できない可能性があります。さらに、健康志向の消費者の間では、包括的な回答を提供する治療法へのニーズが高まっており、咳止めシロップの市場拡大を制限する可能性があります。

小児用咳止めシロップのニーズの高まり

小児の健康に対する意識が高まり、幼児にやさしい薬へのニーズが高まっているため、特に小児用咳止めシロップを作るチャンスがあります。幼児にとって魅力的なフレーバーと正確な用量を持つ製品は、市場で人気を博す可能性があります。さらに、小児消費者の特別なニーズや嗜好に応えることで、メーカーはこのニッチ市場から大きな利益を上げることができます。

価格低下とジェネリック競争

咳止めシロップの市場は、ジェネリック医薬品の競争の可能性によって大きな影響を受ける。咳止めシロップは、特許が切れた後にジェネリック医薬品が市場に出回ると、価格が下落する可能性があります。さらに、有名ブランドの市場シェアと収益性は、ジェネリック医薬品との競争激化によって影響を受ける可能性があり、競争上の優位性を維持するために企業側の戦略的計画が必要となります。

COVID-19の影響：

咳止めシロップ市場は、COVID-19の大流行からさまざまな影響を受けています。呼吸器系の健康への関心の高まりから、当初は咳止めシロップなどの咳止め・風邪薬の需要が急増したが、サプライチェーン、製造、流通の混乱により、業界は困難に直面しました。戸締まり、社会的遠ざけ政策、経済不安は消費者の購買パターンに影響を与え、必需品やインターネット小売店への移行を引き起こしました。さらに、パンデミックは人々の予防医療や一般的な健康の価値に対する意識を高め、それが人々の咳止めシロップに対する感じ方や使い方に影響を与えた可能性があります。

予測期間中、咳止め・鎮咳薬セグメントが最大となる見込み

最もシェアが高いと予測されるセグメントは、咳止め・鎮咳薬です。デキストロメトルファンのような鎮咳剤は、咳をしたくなる衝動を抑えることで作用し、乾燥した効果のない咳を和らげます。このカテゴリーは、眠気を催すことなく効果的に咳の症状を軽減するため、幅広い消費者にアピールします。さらに、鎮咳薬は、しつこい咳を治療するための的を絞ったアプローチのため、市販の咳止めシロップ剤に頻繁に使用されており、これが需要を牽引しています。

予測期間中にCAGRが最も高くなると予想されるオンライン薬局セグメント

市場のCAGRが最も高いのは、咳止めシロップのような市販薬も含まれるオンライン薬局部門です。オンライン薬局は、アクセスのしやすさ、利便性、オンラインショッピングに対する消費者の嗜好などの要因により、ますます普及しています。さらに、顧客はオンライン・プラットフォームの助けを借りて、多数の選択肢にアクセスし、製品を比較し、自宅に居ながらにして購入することができます。COVID-19のパンデミックは、社会的距離を縮める措置のため、オンライン薬局の採用をさらに促進しています。

最大のシェアを持つ地域

北米が咳止めシロップ市場で最大のシェアを占めると予測されています。この地域の特徴は、大規模な消費者基盤、確立された医療インフラ、高い医療意識です。特に冬場は呼吸器系の疾患が多いため、咳止めシロップの需要があります。さらに、北米の市場は、大手製薬会社の存在と市販薬に対する消費者の嗜好によってさらに支えられています。

CAGRが最も高い地域：

咳止めシロップ市場は、欧州地域で最も高いCAGRが見込まれます。この地域は、呼吸器疾患にかかりやすい高齢化社会、確立された医療システム、高い健康意識などの恩恵を受けています。さらに、冬場の風邪やインフルエンザの流行が咳止めシロップの安定した需要に拍車をかけています。欧州は、セルフメディケーションと市販薬の傾向、医薬品研究の進歩により、咳止めシロップ市場の継続的成長が期待できます。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます。

• 企業プロファイル
  • 追加市場参入企業の包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推定・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データ鉱業
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• イントロダクション
• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の咳止めシロップ市場：製品タイプ別

• イントロダクション
• 去痰剤
• 咳止め・鎮咳薬
• 抗ヒスタミン薬
• 併用薬
• その他

第6章 世界の咳止めシロップ市場：年齢層別

• イントロダクション
• 小児
• 成人
• 青少年

第7章 世界の咳止めシロップ市場：流通チャネル別

• イントロダクション
• 小売薬局
• 病院薬局
• オンライン薬局

第8章 世界の咳止めシロップ市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他の欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他のアジア太平洋
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他の南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他の中東・アフリカ

第9章 主要発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイル

• Takeda Pharmaceutical Company Limited
• Abbott Laboratories
• Johnson and Johnson Services, Inc
• Merck & Co., Inc.
• Bayer AG
• Teva Pharmaceuticals Industries Ltd
• Acella Pharmaceuticals, LLC
• Sun Pharmaceutical Industries Ltd.
• Novartis International AG
• Reckitt Benckiser Group Plc.
• F. Hoffmann-La Roche Ltd
• Sanofi
• AstraZeneca PLC
• Pfizer Inc.
• Eli Lilly and Company
• GlaxoSmithKline PLC
• Cipla Ltd

List of Tables

• Table 1 Global Cough Syrup Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
• Table 3 Global Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
• Table 4 Global Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
• Table 5 Global Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
• Table 6 Global Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
• Table 7 Global Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 8 Global Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
• Table 9 Global Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 10 Global Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
• Table 11 Global Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
• Table 12 Global Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 13 Global Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
• Table 14 Global Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
• Table 15 Global Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
• Table 16 North America Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
• Table 17 North America Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
• Table 18 North America Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
• Table 19 North America Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
• Table 20 North America Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
• Table 21 North America Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
• Table 22 North America Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 23 North America Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
• Table 24 North America Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 25 North America Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
• Table 26 North America Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
• Table 27 North America Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 28 North America Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
• Table 29 North America Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
• Table 30 North America Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
• Table 31 Europe Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
• Table 32 Europe Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
• Table 33 Europe Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
• Table 34 Europe Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
• Table 35 Europe Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
• Table 36 Europe Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
• Table 37 Europe Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 38 Europe Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
• Table 39 Europe Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 40 Europe Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
• Table 41 Europe Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
• Table 42 Europe Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 43 Europe Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
• Table 44 Europe Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
• Table 45 Europe Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
• Table 46 Asia Pacific Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
• Table 47 Asia Pacific Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
• Table 48 Asia Pacific Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
• Table 49 Asia Pacific Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
• Table 50 Asia Pacific Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
• Table 51 Asia Pacific Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
• Table 52 Asia Pacific Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 53 Asia Pacific Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
• Table 54 Asia Pacific Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 55 Asia Pacific Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
• Table 56 Asia Pacific Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
• Table 57 Asia Pacific Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 58 Asia Pacific Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
• Table 59 Asia Pacific Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
• Table 60 Asia Pacific Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
• Table 61 South America Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
• Table 62 South America Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
• Table 63 South America Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
• Table 64 South America Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
• Table 65 South America Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
• Table 66 South America Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
• Table 67 South America Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 68 South America Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
• Table 69 South America Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 70 South America Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
• Table 71 South America Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
• Table 72 South America Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 73 South America Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
• Table 74 South America Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
• Table 75 South America Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
• Table 76 Middle East & Africa Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
• Table 77 Middle East & Africa Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
• Table 78 Middle East & Africa Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
• Table 79 Middle East & Africa Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
• Table 80 Middle East & Africa Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
• Table 81 Middle East & Africa Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
• Table 82 Middle East & Africa Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 83 Middle East & Africa Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
• Table 84 Middle East & Africa Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 85 Middle East & Africa Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
• Table 86 Middle East & Africa Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
• Table 87 Middle East & Africa Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 88 Middle East & Africa Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
• Table 89 Middle East & Africa Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
• Table 90 Middle East & Africa Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)

According to Stratistics MRC, the Global Cough Syrup Market is accounted for $6312.09 million in 2023 and is expected to reach $8764.00 million by 2030 growing at a CAGR of 4.8% during the forecast period. An over-the-counter drug that is frequently used to treat cough symptoms is cough syrup. Cough syrup usually contains expectorants, cough suppressants, and occasionally antihistamines as active ingredients. Its main goals are to ease throat irritation, lessen the urge to cough, and encourage mucus loosening. Moreover, some formulations may also contain fever reducers or pain relievers. Cough syrup comes in a variety of forms, such as liquids and syrups, it is simple to use.

According to the American Lung Association, proper respiratory health is crucial for overall well-being, and regular exercise can contribute to maintaining strong lung function.

Market Dynamics:

Driver:

Frequency of respiratory conditions

Cough syrup demand is largely driven by the ongoing prevalence of respiratory conditions like colds, the flu, and allergies. Since many people throughout the world suffer from these illnesses, there is a constant need for cough relief products. Furthermore, cough syrup becomes the go-to option for people looking for quick and efficient relief from irritable symptoms related to respiratory problems.

Restraint:

Limited ability to address fundamental causes

Cough syrups mainly treat the symptoms of respiratory disorders rather than their underlying causes. Although they alleviate coughing and associated discomfort, they might not treat the underlying cause of the illness. Additionally, the need for therapies that provide comprehensive answers is growing among health-conscious consumers, which could limit the market for cough syrup expansion.

Opportunity:

Growing need for children's cough syrups

There's a chance to create pediatric cough syrups specifically because of the growing awareness of pediatric health and the growing need for kid-friendly medications. Products with flavors that appeal to kids and dosages that are accurate can become popular on the market. Moreover, by catering to the particular needs and preferences of pediatric consumers, manufacturers can make significant profits from this market niche.

Threat:

Price erosion and generic competition

The market for cough syrup is severely challenged by the possibility of generic competition. Cough syrups may see price erosion when generic versions hit the market after a patent expires. Additionally, the market share and profitability of well-known brands may be impacted by increased competition from generic alternatives, necessitating strategic planning on the part of businesses to maintain a competitive advantage.

Covid-19 Impact:

The market for cough syrup has seen a variety of effects from the COVID-19 pandemic. Although there was initially a spike in demand for cough and cold remedies, such as cough syrups, due to the increased focus on respiratory health, the industry faced difficulties due to disruptions in supply chains, manufacturing, and distribution. Lockdowns, social distancing policies, and economic uncertainty affected consumer buying patterns, causing a move toward necessities and internet retailers. Furthermore, the pandemic increased people's awareness of the value of preventive care and general health, which may have an effect on how people feel about and use cough syrups.

The Cough Suppressants/Antitussives segment is expected to be the largest during the forecast period

The segment with the largest share is predicted to be cough suppressants and antitussives. Decongestants, like dextromethorphan, act by lessening the urge to cough, which relieves dry, ineffective coughs. This category appeals to a wide range of consumers because it effectively reduces cough symptoms without making people drowsy. Moreover, antitussives are frequently used in over-the-counter cough syrup formulations due to their targeted approach to treating persistent coughing, which drives demand for them.

The Online Pharmacy segment is expected to have the highest CAGR during the forecast period

The market's highest CAGR has been seen in the online pharmacy sector, which also includes over-the-counter drugs like cough syrups. Online pharmacies are becoming more and more popular due to factors like accessibility, convenience, and consumer preference for online shopping. Additionally, customers can access a multitude of options, compare products, and make purchases from the comfort of their homes with the help of the online platform. Due to social distancing measures, the COVID-19 pandemic has expedited the adoption of online pharmacies even more.

Region with largest share:

It is projected that North America will control the largest share of the cough syrup market. The area is distinguished by a sizable consumer base, a well-established healthcare infrastructure, and high healthcare awareness. There is a demand for cough syrups because respiratory conditions are more common, especially in the winter months. Furthermore, the market in North America is further supported by the presence of large pharmaceutical companies and consumer preferences for over-the-counter medications.

Region with highest CAGR:

The cough syrup market is expected to grow at the highest CAGR in the European region. The area benefits from an aging population that is more susceptible to respiratory disorders, a well-established healthcare system, and high health awareness. Additionally, the wintertime cold and flu season's propensity to spread adds to the steady demand for cough syrups. Europe is positioned for continued growth in the cough syrup market due to its propensity for self-medication and over-the-counter remedies, as well as advances in pharmaceutical research.

Key players in the market

Some of the key players in Cough Syrup market include Takeda Pharmaceutical Company Limited, Abbott Laboratories, Johnson and Johnson Services, Inc, Merck & Co., Inc., Bayer AG, Teva Pharmaceuticals Industries Ltd, Acella Pharmaceuticals, LLC, Sun Pharmaceutical Industries Ltd., Novartis International AG, Reckitt Benckiser Group Plc., F. Hoffmann-La Roche Ltd, Sanofi, AstraZeneca PLC, Pfizer Inc., Eli Lilly and Company, GlaxoSmithKline PLC and Cipla Ltd.

Key Developments:

In January 2024, Merck, a leading science and technology company, has announced a licensing agreement with US-based firm Inspirna, Inc. for ompenaclid, a first-in-class oral inhibitor of the creatine transport channel SLC6A8, and SLC6A8-targeting follow-on compounds. Ompenaclid is currently being evaluated in a Phase II study for the second-line treatment of RAS-mutated advanced or metastatic colorectal cancer (mCRC).

In September 2023, Abbott has entered a definitive agreement for the acquisition of Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes. Together, the companies have worked on connected diabetes solutions since 2017. Developed by Bigfoot Biomedical, Bigfoot Unity is a smart insulin management system. It features connected insulin pen caps that use integrated continuous glucose monitoring (iCGM) data and healthcare provider instructions.

In January 2023, Takeda has signed an exclusive licence agreement with HUTCHMED (China) and its subsidiary Hutchmed to develop and market the latter's fruquintinib. Under the deal terms, the company will have an exclusive global licence for the development and commercialisation of fruquintinib for all indications and territories outside of mainland China, Macau, and Hong Kong.

Product Types Covered:

• Expectorants
• Cough Suppressants/Antitussives
• Antihistamines
• Combination Medications
• Other Product Types

Age Groups Covered:

• Pediatric
• Adult
• Adolescents

Distribution Channels Covered:

• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Cough Syrup Market, By Product Type

• 5.1 Introduction
• 5.2 Expectorants
• 5.3 Cough Suppressants/Antitussives
• 5.4 Antihistamines
• 5.5 Combination Medications
• 5.6 Other Product Types

6 Global Cough Syrup Market, By Age Group

• 6.1 Introduction
• 6.2 Pediatric
• 6.3 Adult
• 6.4 Adolescents

7 Global Cough Syrup Market, By Distribution Channel

• 7.1 Introduction
• 7.2 Retail Pharmacy
• 7.3 Hospital Pharmacy
• 7.4 Online Pharmacy

8 Global Cough Syrup Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Takeda Pharmaceutical Company Limited
• 10.2 Abbott Laboratories
• 10.3 Johnson and Johnson Services, Inc
• 10.4 Merck & Co., Inc.
• 10.5 Bayer AG
• 10.6 Teva Pharmaceuticals Industries Ltd
• 10.7 Acella Pharmaceuticals, LLC
• 10.8 Sun Pharmaceutical Industries Ltd.
• 10.9 Novartis International AG
• 10.10 Reckitt Benckiser Group Plc.
• 10.11 F. Hoffmann-La Roche Ltd
• 10.12 Sanofi
• 10.13 AstraZeneca PLC
• 10.14 Pfizer Inc.
• 10.15 Eli Lilly and Company
• 10.16 GlaxoSmithKline PLC
• 10.17 Cipla Ltd